Aging, inflammation, stem cells, and bone healing

Stem Cell Research and Therapy

Volumn 7, Issue 1, 2016, Pages

  Gibon, Emmanuel ^a,b,c   Lu, Laura ^a   Goodman, Stuart B ^a  

^a STANFORD UNIVERSITY   (United States)

^b Paris university   (France)

^c université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT5A PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ADAPTIVE IMMUNITY; AGING; BONE REGENERATION; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL SURVIVAL; FRACTURE HEALING; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE POLARIZATION; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL; REVIEW; STEM CELL; ANIMAL; BONE DEVELOPMENT; FRACTURE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

AGING; ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INFLAMMATION; MACROPHAGES; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; STEM CELLS;

EID: 85007328357     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-016-0300-9     Document Type: Review

References (69)

1. UScensus. U. S. Department of Commerce, Economics and Statistics Administration, U. S. Census Bureau, Washington. 2010. http://www.census. gov/prod/cen2010/briefs/c2010br-09.pdf. Accessed 29 July 2015.
2. Iorio R, Robb WJ, Healy WL, Berry DJ, Hozack WJ, Kyle RF, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90:1598-605.
3. UScensus. U. S. Department of Commerce, Economics and Statistics Administration, U. S. Census Bureau, Washington. 2015. http://www.census. gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf Accessed 29 July 2015.
4. Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004. 5, The Burden of Bone Disease. Available from: http://www.ncbi.nlm. nih.gov/books/NBK45502/. Accessed 29 July 2015.
5. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995;10:1272-81.
6. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs (Print). 2001;169:285-94.
7. Xing Z, Lu C, Hu D, Yu Y-y, Wang X, Colnot C, et al. Multiple roles for CCR2 during fracture healing. Dis Model Mech. 2010;3:451-8.
8. Cho SW. Role of osteal macrophages in bone metabolism. J Pathol Transl Med. 2015;49:102-4.
9. Cho SW, Soki FN, Koh AJ, Eber MR, Entezami P, Park SI, et al. Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proc Natl Acad Sci U S A. 2014;111:1545-50.
10. Alexander KA, Chang MK, Maylin ER, Kohler T, Müller R, Wu AC, et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011;26:1517-32.
11. Pettit AR, Chang MK, Hume DA, Raggatt L-J. Osteal macrophages: a new twist on coupling during bone dynamics. Bone. 2008;43:976-82.
12. Chang MK, Raggatt L-J, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol. 2008;181:1232-44.
13. Phillips AM. Overview of the fracture healing cascade. Injury. 2005;36 Suppl 3:S5-7.
14. Ito H. Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources. Mod Rheumatol. 2011;21:113-21.
15. Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, Midura RJ, et al. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res. 2011;29:1064-9.
16. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009;60:813-23.
17. Granero-Molto F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009;27:1887-98.
18. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the boneforming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells (Dayton, Ohio). 2008;26:223-34.
19. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2009;24:274-82.
20. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008;26:165-75.
21. Ren PG, Huang Z, Ma T, Biswal S, Smith RL, Goodman SB. Surveillance of systemic trafficking of macrophages induced by UHMWPE particles in nude mice by noninvasive imaging. J Biomed Mater Res A. 2010;94:706-11.
22. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14:986-95.
23. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-86.
24. Valladares RD, Nich C, Zwingenberger S, Li C, Swank KR, Gibon E, et al. Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis. J Biomed Mater Res A. 2014;102:3004-11.
25. Rao AJ, Gibon E, Ma T, Yao Z, Smith RL, Goodman SB. Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater. 2012;8:2815-23.
26. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453-61.
27. Guihard P, Boutet MA, Brounais-Le Royer B, Gamblin AL, Amiaud J, Renaud A, et al. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury. Am J Pathol. 2015;185:765-75.
28. Maresz K, Ponomarev ED, Barteneva N, Tan Y, Mann MK, Dittel BN. IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J Reprod Immunol. 2008;78:140-8.
29. Nair MG, Du Y, Perrigoue JG, Zaph C, Taylor JJ, Goldschmidt M, et al. Alternatively activated macrophage-derived RELM-alpha is a negative regulator of type 2 inflammation in the lung. J Exp Med. 2009;206:937-52.
30. Wang Y, Wehling-Henricks M, Samengo G, Tidball JG. Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide. Aging Cell. 2015;14:678-88.
31. Sebastian C, Herrero C, Serra M, Lloberas J, Blasco MA, Celada A. Telomere shortening and oxidative stress in aged macrophages results in impaired STAT5a phosphorylation. J Immunol. 2009;183:2356-64.
32. Aristorena M, Blanco FJ, de Las C-EM, Ojeda-Fernandez L, Gallardo-Vara E, Corbi A, et al. Expression of endoglin isoforms in the myeloid lineage and their role during aging and macrophage polarization. J Cell Sci. 2014;127(Pt 12):2723-35.
33. Ramanathan R, Kohli A, Ingaramo MC, Jain A, Leng SX, Punjabi NM, et al. Serum chitotriosidase, a putative marker of chronically activated macrophages, increases with normal aging. J Gerontol A Biol Sci Med Sci. 2013;68:1303-9.
34. Herrero C, Marques L, Lloberas J, Celada A. IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest. 2001;107:485-93.
35. Gomez CR, Acuna-Castillo C, Nishimura S, Perez V, Escobar A, Salazar-Onfray F, et al. Serum from aged F344 rats conditions the activation of young macrophages. Mech Ageing Dev. 2006;127:257-63.
36. Linehan E, Dombrowski Y, Snoddy R, Fallon PG, Kissenpfennig A, Fitzgerald DC. Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell. 2014;13:699-708.
37. Barrett JP, Costello DA, O'Sullivan J, Cowley TR, Lynch MA. Bone marrow-derived macrophages from aged rats are more responsive to inflammatory stimuli. J Neuroinflammation. 2015;12:67.
38. Stranks AJ, Hansen AL, Panse I, Mortensen M, Ferguson DJ, Puleston DJ, et al. Autophagy controls acquisition of aging features in macrophages. J Innate Immun. 2015;7:375-91.
39. Cecílio CA, Costa EH, Simioni PU, Gabriel DL, Tamashiro WM. Aging alters the production of iNOS, arginase and cytokines in murine macrophages. Braz J Med Biol Res. 2011;44:671-81.
40. Dimitrijevic M, Stanojevic S, Vujic V, Aleksic I, Pilipovic I, Leposavic G. Aging oppositely affects TNF-α and IL-10 production by macrophages from different rat strains. Biogerontology. 2014;15:475-86.
41. Smallwood HS, Lopez-Ferrer D, Squier TC. Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry. 2011;50:9911-22.
42. Ramirez A, Rathinam V, Fitzgerald KA, Golenbock DT, Mathew A. Defective pro-IL-1β responses in macrophages from aged mice. Immun Ageing. 2012;9:27.
43. Jiang M, Xiang Y, Wang D, Gao J, Liu D, Liu Y, et al. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell. 2012;11:29-40.
44. Mahbub S, Deburghgraeve CR, Kovacs EJ. Advanced age impairs macrophage polarization. J Interferon Cytokine Res. 2012;32:18-26.
45. Ding A, Hwang S, Schwab R. Effect of aging on murine macrophages. Diminished response to IFN-gamma for enhanced oxidative metabolism. J Immunol. 1994;153:2146-52.
46. Slade Shantz JA, Yu Y-Y, Andres W, Miclau T, Marcucio R. Modulation of macrophage activity during fracture repair has differential effects in young adult and elderly mice. J Orthop Trauma. 2014;28 Suppl 1:S10-4.
47. Histing T, Kuntz S, Stenger D, Scheuer C, Garcia P, Holstein JH, et al. Delayed fracture healing in aged senescence-accelerated P6 mice. J Invest Surg. 2013;26:30-5.
48. Egermann M, Heil P, Tami A, Ito K, Janicki P, Von Rechenberg B, et al. Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res. 2010;28:798-804.
49. Xing Z, Lu C, Hu D, Miclau T, Marcucio RS. Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res. 2010;28:1000-6.
50. Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, et al. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res. 2009;24:251-64.
51. Lu C, Miclau T, Hu D, Hansen E, Tsui K, Puttlitz C, et al. Cellular basis for age-related changes in fracture repair. J Orthop Res. 2005;23:1300-7.
52. Kovacs EJ. Aging, traumatic injury, and estrogen treatment. Exp Gerontol. 2005;40:549-55.
53. Hernigou P, Poignard A, Zilber S, Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop. 2009;43:40-5.
54. Goodman SB, Hwang KL. Treatment of secondary osteonecrosis of the knee with local debridement and osteoprogenitor cell grafting. J Arthroplasty. 2015;30:1892-6.
55. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 2009;17:939-46.
56. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int. 1995;56:123-9.
57. Chen TL. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone. 2004;35:83-95.
58. Shigeno Y, Ashton BA. Human bone-cell proliferation in vitro decreases with human donor age. J Bone Joint Surg (Br). 1995;77:139-42.
59. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19:117-25.
60. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163-73.
61. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675-82.
62. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Agerelated intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335-43.
63. Kuehn BM. Genetic flaws found in aging stem cell lines. JAMA. 2005;294:1883-4.
64. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999;14:1115-22.
65. Liu L, DiGirolamo CM, Navarro PAAS, Blasco MA, Keefe DL. Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res. 2004;294:1-8.
66. Pignolo RJ, Suda RK, McMillan EA, Shen J, Lee S-H, Choi Y, et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 2008;7:23-31.
67. Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, et al. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells. 2007;25:2371-82.
68. Choudhery MS, Khan M, Mahmood R, Mehmood A, Khan SN, Riazuddin S. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell Biol Int. 2012;36:747-53.
69. Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, et al. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med. 2014;20:265-71.